TrialClinical cancer research : an official journal of the American Association for Cancer Research2014

Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma.

Raffit Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.